Viacheslav Anatolievich Shmarov

Viacheslav Anatolievich Shmarov

Auto-generated profile, based on publicly available information

Viacheslav Anatolievich Shmarov

State Scientific Center of Russian Federation – Institute of Biomedical Problems of Russian Academy of Sciences, Moscow, Russian Federation

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Cellular Immunology
Verified
Journal Article
Closed access
VMVladimir Vladimirovich Malashchenko
Vladimir Vladimirovich Malashchenko
MMMaxsim Evgenievich Meniailo
Maxsim Evgenievich Meniailo
VSViacheslav Anatolievich Shmarov
Viacheslav Anatolievich Shmarov
NGNatalia Dinislamovna Gazatova
Natalia Dinislamovna Gazatova
OMOlga Borisovna Melashchenko
Olga Borisovna Melashchenko
VSVictor Seledtsov
Victor Seledtsov

1 September 2017 in International Immunopharmacology
Verified
Journal Article
Closed access
MMMaksim Evgenievich Meniailo
Maksim Evgenievich Meniailo
VMVladimir Vladimirovich Malashchenko
Vladimir Vladimirovich Malashchenko
VSViacheslav Anatolievich Shmarov
Viacheslav Anatolievich Shmarov
NGNatalia Dinislamovna Gazatova
Natalia Dinislamovna Gazatova
OMOlga Borisovna Melashchenko
Olga Borisovna Melashchenko
VSVictor Seledtsov
Victor Seledtsov

2 November 2022 in npj Microgravity
Verified
Journal Article
Open access
PDF file
DKD. S. Kuzichkin
D. S. Kuzichkin
INI. A. Nichiporuk
I. A. Nichiporuk
OZO. A. Zhuravleva
O. A. Zhuravleva
AMA. A. Markin
A. A. Markin
MRM. P. Rykova
M. P. Rykova
SPSergey Ponomarev
Sergey Ponomarev
Space flight factors are known to cause a malfunction in the human immune system and lead to damage to blood vessels. The hemostatic function of endothelium during space missions and its interaction with human immunity has not been determined so far. In this work, we investigated the markers of endothelial activation and damage (plasma concentrations of soluble thrombomodulin fraction (sTM), von Willebrand factor (vWF), highly sensitive C-reactive protein (hs-CRP)), as well as the level of D-dimer and compared them to the immunological parameters characterizing the state of human humoral and cellular immunity. The immune status of long-duration ISS crewmembers was assessed by whole-blood testing, and comprehensive postflight immune assessment included the analysis of leukocyte distribution. Flow cytometry was applied to determine the absolute counts and the percentage of lymphocyte subsets: B cells (CD19+), T cells (CD3+, CD3+CD4+, CD3+CD8+), NK cells (CD3−CD16+CD56+, CD11b+CD56+), and activated subsets (CD3+CD25+ and CD3+HLA-DR+). The in vitro basal cytokine production was investigated in whole blood cell culture. The cytokines IFN-gamma, IL-1-beta, IL-4, IL-6, IL-10, IL-18, and TNF-alpha were measured in plasma and the 24-h supernatants by a sensitive enzyme-linked immunosorbent assay. A significant increase in the plasma levels of vWF and hs-CRP and a decrease in the concentration of sTM after spaceflights were detected. Divergent changes in the parameters characterizing the state of the immune system were observed. We propose that the changes revealed may lead to an increase in the procoagulant activity of blood plasma, suppression of protein C activation and thrombin inhibition, as well as to an increase in the adhesive-aggregate potential of platelets, especially in case of changes in the rheological characteristics of blood flow during re-adaptation to ground conditions. We also speculate that the immune system might play an important role in vessel damage during long-duration missions.

25 August 2023 in Science Advances
Verified
Journal Article
Open access
CGCarlos J. Gallardo-Dodd
Carlos J. Gallardo-Dodd
COChristian Oertlin
Christian Oertlin
JRJulien Record
Julien Record
RGRômulo G. Galvani
Rômulo G. Galvani
CSChristian Sommerauer
Christian Sommerauer
LWLisa S. Westerberg
Lisa S. Westerberg
The next steps of deep space exploration are manned missions to Moon and Mars. For safe space missions for crew members, it is important to understand the impact of space flight on the immune system. We studied the effects of 21 days dry immersion (DI) exposure on the transcriptomes of T cells isolated from blood samples of eight healthy volunteers. Samples were collected 7 days before DI, at day 7, 14, and 21 during DI, and 7 days after DI. RNA sequencing of CD3 + T cells revealed transcriptional alterations across all time points, with most changes occurring 14 days after DI exposure. At day 21, T cells showed evidence of adaptation with a transcriptional profile resembling that of 7 days before DI. At 7 days after DI, T cells again changed their transcriptional profile. These data suggest that T cells adapt by rewiring their transcriptomes in response to simulated weightlessness and that remodeling cues persist when reexposed to normal gravity.

18 May 2016 in International Immunopharmacology
Verified
Journal Article
Closed access
NTNatalia Todosenko
Natalia Todosenko
VSV.A. Shmarov
V.A. Shmarov
VMV.V. Malashchenko
V.V. Malashchenko
MMM.E. Meniailo
M.E. Meniailo
OMO.B. Melashchenko
O.B. Melashchenko
VSVictor Seledtsov
Victor Seledtsov

1 January 2017 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
MMM. E. Meniailo
M. E. Meniailo
VMV. V. Malashchenko
V. V. Malashchenko
VSV. A. Shmarov
V. A. Shmarov
NGN. D. Gasatova
N. D. Gasatova
OMO. B. Melashchenko
O. B. Melashchenko
VSVictor Seledtsov
Victor Seledtsov
CD3+Т-лимфоциты выделяли из мононуклеарных клеток нормальных доноров методом позитивной магнитной сепарации. Показано, что продукция интерлейкина-8 (interleukin-8, IL-8) Т-клетками возрастала в ответ на их активацию частицами, конъюгированными с антителами к молекулам CD3, СD28 и СD2. Исходно рецептор к IL-8 (CXCR1, CD181) экспрессировался на 13,3% Т-лимфоцитов. Активация Т-лимфоцитов приводила к заметному увеличению содержания CD181+ клеток среди CD4+ наивных Т-лимфоцитов, CD4+ терминально-дифференцированных Т-эффекторов и снижению их числа среди CD4+ клеток эффекторной памяти. Активацию Т-лимфоцитов оценивали по экспрессии молекулы CD25 (рецептор к IL-2). Установлено, что IL-8 в диапазоне концентраций 0,01-10,0 нг/мл способен снижать активацию как CD4-, так и CD4+Т-клеток эффекторной памяти и терминально-дифференцированных Т-эффекторов, не оказывая при этом существенного влияния на активацию наивных Т-лимфоцитов и Т-клеток центральной памяти. IL-8 усиливал продукцию активированными Т-клетками IL-2, снижал продукцию IL-10 и существенно не влиял на секрецию IFNγ и IL-4. Полученные данные указывают на значимость IL-8 в прямой регуляции адаптивных Т-клеточных реакций.